Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Add-on Effects of Valsartan on Morbi- Mortality in High Risk Hypertension

NCT00149227 is registered in ClinicalTrials.gov with Kyoto Prefectural University of Medicine as lead sponsor.

NCT NCT00149227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00149227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Add-on Effects of Valsartan on Morbi- Mortality in High Risk Hypertension
Lead sponsor
Kyoto Prefectural University of Medicine
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2004
Completion date
January 31, 2009
Enrollment
3,031 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure, hypertension, ischemic heart disease, stroke